UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by AustralianSuper Pty Ltd

AustralianSuper Pty Ltd decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 26.0% during the fourth quarter, Holdings Channel.com reports. The fund owned 411,899 shares of the healthcare conglomerate’s stock after selling 144,997 shares during the period. UnitedHealth Group accounts for approximately 1.0% of AustralianSuper Pty Ltd’s holdings, making the stock its 20th biggest holding. AustralianSuper Pty Ltd’s holdings in UnitedHealth Group were worth $208,363,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Chevy Chase Trust Holdings LLC raised its holdings in shares of UnitedHealth Group by 4.3% in the fourth quarter. Chevy Chase Trust Holdings LLC now owns 697,335 shares of the healthcare conglomerate’s stock worth $352,754,000 after buying an additional 28,940 shares during the last quarter. Campbell Wealth Management raised its stake in UnitedHealth Group by 27.7% in the 4th quarter. Campbell Wealth Management now owns 502 shares of the healthcare conglomerate’s stock worth $254,000 after acquiring an additional 109 shares during the last quarter. Asset Planning Inc purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $1,058,000. Vicus Capital increased its holdings in UnitedHealth Group by 12.0% in the 4th quarter. Vicus Capital now owns 541 shares of the healthcare conglomerate’s stock worth $274,000 after buying an additional 58 shares during the period. Finally, Pictet North America Advisors SA boosted its holdings in shares of UnitedHealth Group by 0.7% in the 4th quarter. Pictet North America Advisors SA now owns 19,517 shares of the healthcare conglomerate’s stock valued at $9,873,000 after acquiring an additional 132 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Truist Financial decreased their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Up 0.7 %

Shares of UnitedHealth Group stock opened at $531.31 on Friday. The stock has a market cap of $488.96 billion, a price-to-earnings ratio of 34.28, a PEG ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a fifty day simple moving average of $524.58 and a 200-day simple moving average of $563.71. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company posted $5.83 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.